Clinical Trial Update: A Study of Oprozomib, Melphalan, and Prednisone in Transplant Ineligible Patients With Newly Diagnosed Multiple Myeloma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 trial evaluating Oprozomib in combination with Melphalan and Prednisone in transplant-ineligible patients with newly diagnosed multiple myelom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Melphalan (Melphalan)
• Oprozomib (oprozomib)
• PREDNISONE (Prednisone)

Snippet

Sponsor: Amgen | Conditions: Multiple Myeloma | Phase 1, Phase 2 | Status: COMPLETED